Shi CS - Search Results

1

Therapeutic Potential of Regorafenib in Cisplatin-Resistant Bladder Cancer with High Epithelial-Mesenchymal Transition and Stemness Properties.

Kuan FC, Li JM, Huang YC, Chang SF, Shi CS. Kuan FC, et al. Among authors: shi cs. Int J Mol Sci. 2023 Dec 18;24(24):17610. doi: 10.3390/ijms242417610. Int J Mol Sci. 2023. PMID: 38139437 Free PMC article.

2

Modulation of mitochondrial apoptosis by β2-adrenergic receptor blockage in colorectal cancer after radiotherapy: an in-vivo and in-vitro study.

Shi CS, Kuan FC, Chin CC, Li JM. Shi CS, et al. Am J Cancer Res. 2023 Aug 15;13(8):3741-3752. eCollection 2023. Am J Cancer Res. 2023. PMID: 37693145 Free PMC article.

3

The role of lactoferrin in bone remodeling: evaluation of its potential in targeted delivery and treatment of metabolic bone diseases and orthopedic conditions.

Tian M, Han YB, Yang GY, Li JL, Shi CS, Tian D. Tian M, et al. Among authors: shi cs. Front Endocrinol (Lausanne). 2023 Aug 23;14:1218148. doi: 10.3389/fendo.2023.1218148. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37680888 Free PMC article. Review.

4

MicroRNA-204-5p Ameliorates Neurological Injury via the EphA4/PI3K/AKT Signaling Pathway in Ischemic Stroke.

Shi CS, Hu Q, Fang SL, Sun CX, Shao DH. Shi CS, et al. ACS Chem Neurosci. 2023 Jun 7;14(11):2060-2073. doi: 10.1021/acschemneuro.3c00047. Epub 2023 May 17. ACS Chem Neurosci. 2023. PMID: 37196241

5

The Impact of Human Platelet Antigen Allele on Antiplatelet Antibodies and Cryoglobulins in Patients with Primary Immune Thrombocytopenia and Hepatitis C Virus-Associated Immune Thrombocytopenia.

Huang CE, Chen YY, Chang JJ, Wu YY, Chen WM, Wang YH, Chen MC, Lu CH, Shi CS, Chen CC. Huang CE, et al. Among authors: shi cs. Mediterr J Hematol Infect Dis. 2023 May 1;15(1):e2023030. doi: 10.4084/MJHID.2023.030. eCollection 2023. Mediterr J Hematol Infect Dis. 2023. PMID: 37180208 Free PMC article.

6

The impact of sarcopenia on overall survival in patients with pan-RAS wild-type colorectal liver metastasis receiving hepatectomy.

Yang YR, Shi CS, Chang SW, Wu YY, Su YL, Lin GP, Kuan FC. Yang YR, et al. Among authors: shi cs. Sci Rep. 2023 Apr 27;13(1):6911. doi: 10.1038/s41598-023-33439-x. Sci Rep. 2023. PMID: 37106073 Free PMC article.

7

Inflammation in Hernia and the epigenetic control.

Li JL, Han YB, Yang GY, Tian M, Shi CS, Tian D. Li JL, et al. Among authors: shi cs. Semin Cell Dev Biol. 2024 Feb 15;154(Pt C):334-339. doi: 10.1016/j.semcdb.2023.04.002. Epub 2023 Apr 18. Semin Cell Dev Biol. 2024. PMID: 37080853 Review.

8

The cancer stemness inhibitor napabucasin suppresses small cell lung cancer growth through SOX2 expression.

Li JM, Hsu PC, Kuan FC, Shi CS, Yang CT. Li JM, et al. Among authors: shi cs. Am J Cancer Res. 2022 Oct 15;12(10):4637-4651. eCollection 2022. Am J Cancer Res. 2022. PMID: 36381330 Free PMC article.

9

Inhibition of Neddylation Suppresses Osteoclast Differentiation and Function In Vitro and Alleviates Osteoporosis In Vivo.

Wu MH, Hsu WB, Chen MH, Shi CS. Wu MH, et al. Among authors: shi cs. Biomedicines. 2022 Sep 21;10(10):2355. doi: 10.3390/biomedicines10102355. Biomedicines. 2022. PMID: 36289618 Free PMC article.

10

Predicting Outcome in Combination Treatment of TACE and Camrelizumab for Advanced Hepatocellular carcinoma: Tumor Hypervascularity and Reactive Cutaneous Capillary Endothelial Proliferation.

Yin L, Liu KC, Lv WF, Xu SB, Lu D, Zhou CZ, Cheng DL, Gao ZG, Shi CS, Su MX. Yin L, et al. Among authors: shi cs. Drug Des Devel Ther. 2022 Sep 30;16:3421-3429. doi: 10.2147/DDDT.S372276. eCollection 2022. Drug Des Devel Ther. 2022. PMID: 36203820 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

146 results

Search Page